Skin cancer breakthrough - Gene explains why men are at higher risk of malignant melanomaNovember 26, 2003Researchers from Germany have identified a gene that is associated with an increased risk of suffering from skin cancer. The research, published this month in Journal of Carcinogenesis, could also explain why men are more likely to suffer from malignant melanoma than women. Although most people associate melanoma with exposure to UV light, through excessive sunbathing for example, the disease can be inherited - indicating that faulty genes are also partly to blame. Genetic risk factors also affect the likelihood of individuals suffering from non-inherited, or sporadic, melanoma. To identify these risk factors, researchers from the University Hospital in Tuebingen took blood samples from 450 healthy volunteers, and 500 people who had been diagnosed with malignant melanoma, from which they could extract DNA. In collaboration with Genefinder Technologies Ltd., Munich, Germany and Sequenom Inc., San Diego, USA, the researchers studied the DNA samples, looking for slight differences in the genes between people with melanoma skin cancer and people with no cancers at all. To do this they screened more than 25,000 sites across the whole genome, which are known to vary naturally between different people. The researchers identified a gene called BRAF that contains several sites of natural variation. Some variants were more likely to be found in people who suffered from melanoma than in those that did not. But, when the data was separated by sex, it appeared that the variants only conferred a higher risk of suffering from melanoma on men who carried them. At present, men have a 1 in 58 chance, and women a 1 in 82 chance of developing the disease in their lifetime. The researchers write: "BRAF may be one explanation of why males have an increased lifetime incidence of melanoma compared to females". Until now, the best-known risk factor for melanoma was if you had a mutated copy of the gene CDKN2A. This gene could explain about 25% of the inherited cases of melanoma, which equates to about 1% of the total number of cases. The risk associated with BRAF is much more significant. The researchers write: "We estimate that BRAF could account for an attributable risk of developing melanoma of approximately 4% in the German population. This risk estimate is much higher than that attributed to CDKN2A." Dr Peter Meyer, the managing researcher of this study, said: "It will be exciting to learn more about whether BRAF is also associated with melanoma-risk in other populations with higher melanoma incidences like Australians." The BRAF gene encodes a protein that activates the growth and multiplication of cells. Recent studies have shown that mutations in BRAF, which cause the protein to become more active, are commonly found in melanomas and moles. The variants that have been identified in this study do not have any effects on the activity of the protein - how they increase the risk of suffering from melanoma is currently unknown. Professor Claus Garbe, the principal investigator of the project said: "Moles are a major risk factor for the development of malignant melanoma. BRAF mutations occur in the majority of melanomas but also in moles. We are therefore interested in addressing the question of whether carrying certain variants of the BRAF gene could predispose people to having or developing more moles, and thus to an increased risk of developing melanoma" Dr Goppala Kovvali, the Editor-in-chief of Journal of Carcinogenesis said: "This article is an important contribution to the field of carcinogenesis. I anticipate that several studies will be undertaken to investigate the BRAF gene in connection with melanoma, especially in the United States and Australia where skin cancer is one of the common cancers." The incidence of malignant melanoma has rapidly increased in recent years. It is the leading cause of death from skin disease, as once the cancer has spread it is resistant to most available treatments. | |||||||||||||||||||||
|
Related Skin Cancer Current Events and Skin Cancer News Articles New breast imaging technology targets hard-to-detect cancers Breast-specific gamma imaging (BSGI) is effective in the detection of cancers not found on mammograms or by clinical exam, according to a study presented today at the annual meeting of the Radiological Society of North America (RSNA). Lung airway cells activate vitamin D and increase immune response Vitamin D is essential to good health but needs to be activated to function properly in the human body. Until recently, this activation was thought to happen primarily in the kidneys, but a new University of Iowa study finds that the activation step can also occur in lung airway cells. Chronic inflammation can help nurture skin cancer, study shows Inflammation, a frontline defense against infection or disease, can help nurture skin cancer, researchers have found. Children with cystic fibrosis not well covered by guidelines for vitamin D needs Existing recommendations for treating vitamin D deficiency in children with cystic fibrosis (CF) are too low to cover the serious need, leaving most at high risk for bone loss and rickets, according to researchers at Johns Hopkins Children's Center. 2008 ozone hole larger than last year The 2008 ozone hole - a thinning in the ozone layer over Antarctica - is larger both in size and ozone loss than 2007 but is not as large as 2006. Pitt research indicates new virus is culprit, not bystander, in deadly skin cancer University of Pittsburgh scientists are uncovering more evidence that a virus they recently discovered is the cause of Merkel cell carcinoma, an aggressive and deadly form of skin cancer. Variant of vitamin D receptor gene linked to melanoma risk A new analysis indicates an association between a gene involved in vitamin D metabolism and skin cancer. Published in the November 1, 2008 issue of CANCER, a peer-reviewed journal of the American Cancer Society, the study suggests that individuals with certain variants in a vitamin D-related gene, called BsmI, may be at an increased risk of developing melanoma. History of nonmelanoma skin cancer is associated with increased risk for subsequent malignancies Individuals with a history of nonmelanoma skin cancer (NMSC) are at increased risk for other cancers, according to a study published in the August 26 online issue of the Journal of the National Cancer Institute. Researchers discover how rheumatoid arthritis causes bone loss Researchers have discovered key details of how rheumatoid arthritis (RA) destroys bone, according to a study published in the Aug. 22 edition of the Journal of Biological Chemistry. Researchers discover scent of skin cancer According to new research from the Monell Center, odors from skin can be used to identify basal cell carcinoma, the most common form of skin cancer. The findings, presented at the 236th meeting of the American Chemical Society, may open doors to development of new methods to detect basal cell carcinoma and other forms of skin cancer. More Skin Cancer Current Events and Skin Cancer News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||